Don’t forget you can visit MyAlerts to manage your alerts at any time.
1,007 results for 'Akin////////// industry:"Pharmaceuticals"' You can use Search Constraints to get even better search results
January 23, 2020 | Law.com
Welcome to Labor of Law. Two pharma companies and their Big Law attorneys are facing off in courts around the country over noncompete agreements. Plus: the US Supreme Court is pitched on an ERISA case, and Seyfarth plans to take a major gender-bias class action to the justices soon. Scroll down for Who Got the Work, notable moves and much more!
1 minute read
December 29, 2019 | The American Lawyer
These law firms delivered reliable results, breaking new ground when their clients needed it most.
1 minute read
December 12, 2019 | Law.com
Welcome to Higher Law -- two firms are joining forces, and we've got highlights below. Plus, the SEC hits a cannabis stock promoter, and Akin Gump's lobbying on CBD. Scroll down for notable headlines and more. Thanks for reading!
1 minute read
December 5, 2019 | Law.com
Welcome to Higher Law. We're taking the pulse of various CBD issues, and scroll down to see which Big Law firms are lobbying in this space. Plus: two cannabis law veterans move to Vicente Sederberg, and Fisher & Phillips hires an ex-cannabis general counsel. Thanks for reading!
1 minute read
November 21, 2019 | New York Law Journal
Elazar Guttman, a Kirkland & Ellis equity partner who spent his 17-year career at the firm, moved to Akin Gump on Thursday. Guttman said he expected his practice would be a "perfect blend" of work for Akin Gump clients and those from his own book of business.
1 minute read
Publication Date: 2019-11-12
Practice Area: Antitrust
Industry: Pharmaceuticals
Court: U.S. Court of Appeals for the Second Circuit
Judge: Circuit Judge Denny Chin
Attorneys: For plaintiff: For Plaintiff-Appellant: Gregory G. Rapawy and Julius P. Taranto, on the brief, David C. Frederick, Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C, Washington, DC, and Albert Feinstein, Feinstein & Partners, P.L.L.C., New York, New York.
for defendant: For Defendant-Appellee Genentech, Inc.: Amanda P. Reeves, Roman Martinez, Benjamin W. Snyder, and Lawrence E. Buterman, on the brief, Daniel M. Wall, Latham & Watkins LLP, New York, New York; San Francisco, California; and Washington, DC.
For Defendants-Appellees F. Hoffmann-La Roche Ltd and Roche Holding AG: Andrew S. Gehring, on the brief, Paul Spagnoletti, Davis Polk & Wardell LLP, New York, New York.
For Defendant-Appellee R-Pharm JSC: Caitlin J. Halligan, Eric J. Stock, and Alejandro A. Herrera, Gibson, Dunn & Crutcher LLP, New York, New York.
Case Number: 17-3486
Foreign Nature of Drug Firm's Claims Placed Them Beyond Reach of U.S. Antitrust Laws
October 23, 2019 | New Jersey Law Journal
Lawyers believe the litigation landscape facing Johnson & Johnson could get worse given the unfriendly view the public has of drug companies.
1 minute read
October 22, 2019 | Law.com
Kudelski Group veterans launch a defensive patent aggregator for video.
1 minute read
Publication Date: 2019-09-12
Practice Area: Criminal Law | Evidence
Industry:
Court: U.S. District Court for the Western District of New York, U.S. - WDNY
Judge: District Judge Charles Siragusa
Attorneys: For plaintiff:
for defendant:
Case Number: 17-CR-6017
LCN DNA Test Results Satisfy 'Daubert'/Rule 702, 'Frye' Requirements for Admissibility
August 14, 2019 | Litigation Daily
The Senate will weigh the ex-Alito clerk and former Kirkland & Ellis partner for the circuit judgeship. Another new nominee, Sarah Pitlyk, was a former clerk to then-Judge Brett Kavanaugh on the D.C. Circuit.
1 minute read
Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.
